Literature DB >> 3490173

Bone marrow manifestations of peripheral T-cell lymphoma. A study of 30 cases.

C A Hanson, R D Brunning, K J Gajl-Peczalska, G Frizzera, R W McKenna.   

Abstract

Morphologic and clinical features of 30 patients with peripheral T-cell lymphoma (PTCL) were studied with particular attention to bone marrow and blood manifestations. Twenty-four (80%) patients had marrow involvement with lymphoma in trephine biopsies at initial diagnosis; two other patients subsequently developed marrow involvement. The bone marrow lesions were diffuse in 58% of the cases and focal, nonparatrabecular in 42%. A morphologic spectrum of lymphoma cells was seen with cases classified into small cell, mixed cell, and large cell/immunoblastic lymphoma. The bone marrow lesions were characterized by a heteromorphous population of lymphocytes, prominent vascularity with endothelial cell proliferation, reticulin fibrosis, and a polycellular infiltrate composed of plasma cells, eosinophils, and histiocytes. The histopathologic features in bone marrow biopsies were not pathognomonic for PTCL; the differential diagnosis may include non-Hodgkin's lymphomas of B-cell type, polymorphous reactive lymphoid lesions, including those from patients with acquired immune deficiency syndrome (AIDS), angioimmunoblastic lymphadenopathy, Hodgkin's disease, and systemic mastocytosis. The patients ranged in age from 13 to 81 years (median, 61 years) and generally presented with constitutional symptoms, lymphadenopathy, and hepatosplenomegaly. Abnormalities in one or more hematologic parameters were common and, in general, related to the degree of bone marrow involvement. Hypocalcemia was found in 40% of the patients studied and hypercalcemia in 4%. The median survival for PTCL patients was 11 months. Patients with small cell lymphoma, large cell/immunoblastic lymphoma, and marked eosinophilia had the shortest median survivals.

Entities:  

Mesh:

Year:  1986        PMID: 3490173     DOI: 10.1093/ajcp/86.4.449

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

1.  Evidence for an osteoblast-activating factor in a patient with peripheral T-cell lymphoma and osteosclerosis.

Authors:  M Hüfner; H Döhner; J Schmidt; P Möller; A D Ho; W Hunstein
Journal:  Klin Wochenschr       Date:  1989-04-03

2.  Peripheral T cell lymphoma: value of bone marrow trephine immunophenotyping.

Authors:  D M White; A G Smith; J M Whitehouse; J L Smith
Journal:  J Clin Pathol       Date:  1989-04       Impact factor: 3.411

3.  Significance of clinical factors as prognostic indicators for patients with peripheral T-cell non-Hodgkin lymphoma: A retrospective analysis of 252 cases.

Authors:  Wanzhuo Xie; Keyue Hu; Fan Xu; DE Zhou; Weijia Huang; Jingsong He; Jimin Shi; Yi Luo; Jie Zhang; Maofang Lin; Xiujin Ye; Zhen Cai; He Huang
Journal:  Mol Clin Oncol       Date:  2013-07-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.